Latest Strategy News

Ryder Capital has announced a 10% increase in its FY25 final dividend, underpinned by a 20% rise in total comprehensive income and a 27.5% jump in pre-tax net tangible assets. The company’s robust portfolio performance and strategic share buybacks signal confidence in sustained shareholder returns.

Wellnex Life announces the resignation of joint CEO George Karafotias, with Zack Bozinovski stepping up as sole CEO. The company plans to repay a $705,000 director loan within 90 days.

Neurizon Therapeutics faces a delay in FDA review for its lead ALS therapy NUZ-001, with a new decision expected by early October amid agency-wide staffing challenges.

Falcon Metals has raised A$20 million through a strongly supported placement to fund extensive diamond drilling at its Blue Moon gold prospect near Bendigo. The capital injection underscores institutional confidence in the company’s exploration strategy and high-grade gold potential.

Mount Ridley Mines has announced a capital raising of up to $830,388 through a placement and a pro-rata rights issue, aiming to fund ongoing projects and explore new mining opportunities.

Somerset Minerals (ASX – SMM) is advancing its Coppermine Project in Canada with promising maiden drill results and a $4 million placement to fund expanded exploration.

Centuria Office REIT reported steady FY25 results, maintaining high occupancy and rental growth, alongside a notable $18 million uplift in portfolio valuation. The REIT’s FY26 guidance signals continued stability amid constrained office supply and proactive capital management.

Mirvac Group reported a solid FY25 with $736 million EBIT and expanded its Build-to-Rent portfolio, while guiding for EPS growth in FY26 amid a supportive market backdrop.

Magellan Asset Management is set to overhaul its High Conviction Trust Active ETF by adopting the Global Opportunities Strategy, cutting fees and appointing a new portfolio manager.

Somerset Minerals has raised $4 million to fund an aggressive Phase Two exploration campaign at its Coppermine copper project in Nunavut, aiming to build on strong initial drilling results and unlock multiple new discoveries across a vast landholding.

EMVision Medical Devices has been awarded a $3 million non-dilutive government grant to conduct a pioneering clinical study using its telehealth-enabled emu™ brain scanner in regional South Australia, aiming to transform stroke diagnosis and treatment.

McPherson’s Limited has finalized a key pharmacy wholesaler agreement with API Services Australia, marking the completion of its new distribution model and transitioning significant revenue previously handled direct-to-store.